Emerging Tests: Medicare to Cover Next Gen-Sequencing Tests for Advanced Cancer

 Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
March 27, 2018  
placeholder COVERAGE
Emerging Tests: Medicare to Cover Next Gen-Sequencing Tests for Advanced Cancer
From - Laboratory Industry Report
In the PAMA era, there are two salient trends in Medicare Part B lab reimbursements…
Read More
placeholder GENETIC TESTING
Tests Emerging to Advance Cardiovascular Risk Assessment
From - Diagnostic Testing & Emerging Technologies
While testing for cardiovascular conditions does not garner the headlines that oncology testing does, several recent studies demonstrate…
Read More
     
placeholder NEWS AT A GLANCE
Case of the Month: $11.4 Million Natera Settlement Shows Genetic Billing & Coding Remains a False Claims Hot Button
From - G2 Compliance Advisor
Before the opioid crackdown, false billing of genetic tests was the hottest thing in federal fraud enforcement against…
Read More
placeholder OPIOIDS
Enforcement Trends: Labs Getting Swept into the Opioid Crackdown Vortex
From - National Intelligence Report
Best known for its employment applications, urine drug testing is also medical protocol for patients prescribed opioid drugs. Urine tests are…
Read More

 

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2018, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320